Martin H. Falk

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.

M. Socinski, F. Shepherd, A. Szczesna, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.